Aggressive large B-cell lymphoma triggered by a parvovirus B19 infection in a previously healthy child

Hematol Oncol. 2019 Oct;37(4):483-486. doi: 10.1002/hon.2665. Epub 2019 Aug 25.

Abstract

In absence of red blood cells disease or immune defect, parvovirus B19 (PVB-19) is usually considered as a benign condition. Here, we report the case of a 10-year-old boy, previously healthy, presenting with a PVB-19 infection revealed by a bicytopenia and a voluminous axillary adenopathy. Pathophysiology examination showed reactional lymphoid population. Nine months later and in the absence of remission, a new biopsy of the same adenopathy revealed a Hodgkin lymphoma with area of T-cell rich aggressive large B-cell lymphoma. This case suggests PVB-19 as potential trigger of this malignant childhood hemopathy. Although no definitive conclusion can be drawn, our clinical case questions the role of PVB-19 in lymphomagenesis.

Keywords: cytopenia; large B-cell lymphoma; lymphadenopathy; lymphomagenesis; parvovirus B19.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • B-Lymphocytes / pathology
  • Bone Marrow / pathology
  • Bone Marrow / virology
  • Child
  • Erythema Infectiosum / blood
  • Erythema Infectiosum / complications*
  • Erythema Infectiosum / pathology
  • Erythema Infectiosum / virology
  • Exome Sequencing
  • Hodgkin Disease / etiology*
  • Hodgkin Disease / pathology
  • Humans
  • Lymphoma, B-Cell / etiology*
  • Lymphoma, B-Cell / pathology
  • Male
  • Neoplasms, Multiple Primary / etiology*
  • Neoplasms, Multiple Primary / pathology
  • Pancytopenia / etiology
  • Pseudolymphoma / etiology
  • Remission Induction
  • Rituximab / administration & dosage
  • T-Lymphocytes / pathology
  • Viremia / complications*

Substances

  • Rituximab